The regenerative medicine field is seeing an increasing interest and demand for stem cells in both research and clinical applications. As new stem cell therapies require a large number of high-quality cells, which cannot be made in a reproducible manner using current 2D culture systems, the field is transitioning from a 2D-based approach into bioreactor systems in order to achieve the cell numbers that are needed.
In this panel discussion from Eppendorf, we hear from a range of experts on the use of stem cells in modern medicine, from research through to clinical applications. This includes current trends, applications, challenges, and future developments.
This article is part of the RegMedNet Spotlight on acellular regenerative medicine. Click here to view the full feature and discover expert insights on this >>>